Brief: Intelgenx Receives Amended Del License To Conduct Third-Party Testing
17/05/2023 13:08
Intelgenx Technologies Corp IGX.TO :
* INTELGENX RECEIVES AMENDED DEL LICENSE TO CONDUCT
THIRD-PARTY
TESTING
* INTELGENX TECHNOLOGIES - RECEIVED AMENDED DRUG
ESTABLISHMENT
LICENSE FROM HEALTH CANADA, ALLOWING CO TO CONDUCT THIRD-PARTY
TESTING
Source text for Eikon: ID:nGNX7sBfCF
Further company coverage: IGX.TO
Recent news on Intelgenx Technologies
See all newsBrief: Intelgenx Obtains Court-Approval Of Sale & Investment Solicitation Process
Brief: Intelgenx Initiates Restructuring Proceedings Under CCAA To Implement Review Of Its Strategic Alternatives
Brief: Intelgenx Initiates Restructuring Proceedings Under The CCAA
Brief: IntelGenx Says First Parkinson’s Disease Patients Dosed With Montelukast VersaFilm in Mid-Stage Clinical Trial
Brief: IntelGenx Updates Status Of Buprenorphine Buccal Film ANDA